The starting dose of tirzepatide is 2.5 mg once a week, and after 4 weeks, the dose is increased to the therapeutic dose of 5 mg and administered subcutaneously in patients with T2D
Introduction In the landscape of modern medicine, the treatment of chronic conditions such as type 2 diabetes, obesity, and thyroid disorders represents a significant challenge due to their complex interrelations and the nuanced understanding required to manage them effectively
Certain drugs can lead to dark stools, resembling those caused by more severe health issues
The effects of sarcopenia are further complicated if you decide to stop taking a GLP-1 and then gain weight, Dr
FVP: fourier visual prompting for source-free unsupervised domain adaptation of medical image segmentation
Most are gastrointestinal, tend to be mild to moderate, and often improve as your body adjusts and as doses are increased slowly